TRANSACTION REPORT · SEC DISCLOSURES
Gross proceeds$1.1M
Offering price$1.46
Discount to prior close8.8%
Warrant coverage—
Placement agent / underwriterDawson James Securities, Inc.
Transaction overview
01Alaunos Therapeutics, Inc. completed a $1.1M registered direct at $1.46 per share. Dawson James Securities, Inc. acted as placement agent for the financing.
- Financing type
- Registered Direct
- Announcement date
- Sep 18, 2026
- Pricing date
- Sep 18, 2026
- Closing date
- Sep 21, 2026
- Filing date
- Sep 22, 2026
- Status
- Closed
- Market cap before announcement
- $3.9M
- Prior closing price
- $1.60
- Raise as % of market cap
- 28.8%
Market data · FMP
- Historical market cap
- $3,890,712
- Market date
- Sep 17, 2026
- Closing price
- $1.60
- Latest reported shares outstanding
- 2,442,146
- Latest reported float shares
- 1,866,481
- Share-data date
- Sep 30, 2026
Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Oct 1, 2026.
Financial Modeling Prep ↗Financing terms
02Equity
- Common shares issued
- 380,469
- Price per share
- $1.46
- Pre-funded warrants
- 386,654
- Pre-financing shares disclosed in filing
- —
- Shares outstanding after financing
- —
Fees & transaction economics
03- Placement agent / underwriting fee
- 8%
- Agent fee amount
- $89,600
- Management fee
- —
- Other offering expenses (estimated)
- —
- Net proceeds (estimated)
- $915,400.5
- Net proceeds as % of gross
- 81.7%
Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.
Transaction participants
04Investor names: —
Source documents
05SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.
8-K · Alaunos Therapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗EX-10.1 · Alaunos Therapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗EX-10.2 · Alaunos Therapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗EX-10.3 · Alaunos Therapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗EX-4.1 · Alaunos Therapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗EX-5.1 · Alaunos Therapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗EX-99.1 · Alaunos Therapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗FMP historical market data · TCRTMarket data · Sep 17, 2026
Open source ↗Filing evidence & original calculations
market Cap
FMP reported market cap; as of 2026-09-17.
{"provider": "FMP", "symbol": "TCRT", "date": "2026-09-17", "marketCap": 3890712}Original source ↗